CONMED declares $0.20 quarterly dividend payable July 5, 2023

Advisory vote on Named Executive Officer Compensation 26,472,625 1,750,517 21,033 833,681

Item 5.07 Submission of Matters to a Vote of Security Holders. The Annual Meeting was held on May 24, 2023. Holders of CONMED common stock were entitled to elect nine directors. On all matters which came before the Annual Meeting, holders of CONMED common stock were entitled to one vote for each share held. Proxies for 29,077,857 of the 30,560,476 shares of CONMED common stock entitled to vote were received in connection with the Annual Meeting. The following table sets forth the names of the nine persons elected at the Annual Meeting to serve as directors until the first annual meeting of shareholders following the end of the Company’s fiscal year ending December 31, 2023 and the number of votes cast for, against or withheld with respect to each person. 1. Election of Directors Director Votes Received Votes Withheld Broker Non-Votes David Bronson 27,586,738 657,437 833,681 Brian Concannon 27,642,732 601,443 833,681 LaVerne Council 27,667,570 576,605 833,681 Charles Farkas 27,727,684 5

Ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the Company for the fiscal year ending December 31, 2023 26,610,832 2,461,523 5,501 0

Advisory vote on Frequency of Advisory Vote on Named Executive Officer Compensation 27,903,715 9,418 323,593 7,449 833,681

Amend Certificate of Incorporation to Reflect New Delaware Law Provisions Regarding Exculpation of Certain Officers 22,637,046 5,595,512 11,617 833,681